Keverprazan Hydrochloride manufacturers
|
| | Keverprazan Hydrochloride Basic information |
| Product Name: | Keverprazan Hydrochloride | | Synonyms: | 1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl-, hydrochloride (1:1);P-CAB agent 2 hydrochloride;1-(5-(2-Fluorophenyl)-1-((3-(3-methoxypropoxy)phenyl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine hydrochloride;Carenoprazan HCl;Keverprazan Hydrochloride | | CAS: | 2209911-80-6 | | MF: | C22H26ClFN2O4S | | MW: | 468.97 | | EINECS: | | | Product Categories: | | | Mol File: | 2209911-80-6.mol |  |
| | Keverprazan Hydrochloride Chemical Properties |
| form | Solid | | color | Off-white to light yellow |
| | Keverprazan Hydrochloride Usage And Synthesis |
| Uses | P-CAB agent 2 hydrochloride is a potent and orally active potassium-competitive acid blocker and a gastric acid secretion inhibitor. P-CAB agent 2 hydrochloride inhibits H+/K+-ATPase activity with an IC50 value of <100 nM. P-CAB agent 2 hydrochloride inhibits the hERG potassium channel with an IC50 value of 18.69 M. P-CAB agent 2 hydrochloride shows no acute toxicity and inhibits histamine (HY-B1204)-induced gastric acid secretion[1]. | | in vivo | P-CAB agent 2 hydrochloride (example 1) inhibits histamine (HY-B1204)-induced gastric acid secretion in SD rats[1].
P-CAB agent 2 hydrochloride (600, 2000 mg/kg; p.o.; once) shows no acute toxicity and 600mg/kg shows no significant effect on animal body weight in SD rats[1]. | Animal Model: | 180-220 g, SPF grade, male SD rats[1] | | Dosage: | 2 mg/kg | | Administration: | P.o.; once | | Result: | Inhibited histamine-induced gastric acid secretion with the acid suppression rate of 55.4%. |
| | References | [1] YinLin Qin, et al. Pyrrole sulfonyl derivative, and preparation method and medical use thereof. WO2016119505A1. |
| | Keverprazan Hydrochloride Preparation Products And Raw materials |
|